Tuesday in Philadelphia, at the World Drug Safety Congress 2019 (April 16-17), Asymmetrex introduces its AlphaSTEM Test™ to the international pharmaceutical community. By early detection of drug candidates that are stem cell-toxic, Asymmetrex can eliminate drugs that will fail late after great cost because they induce chronic organ failure. By assaying for toxic effects on
This week The CRISPR Journal released the articles that people are talking about, and Asymmetrex’s article on p53 and CRISPR/Cas9 made the list. This article is free to read until February 7, 2019. “I wish to suggest another explanation for the worrisome observations based on often overlooked properties of p53 as a regulator of postnatal
Now in its fifth month, Massachusetts stem cell biotechnology company Asymmetrex continues its campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine. Now targeting patients and patient advocacy groups, for the month of January, the company’s director is featured on the Parents’ Guide to Cord Blood website with
Since September 2018, Massachusetts stem cell biotechnology company Asymmetrex has been pursuing a campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine and the stem cell supply industry. The latest 2018 installment in this effort is a book chapter, authored by Asymmetrex’s founder and director, that illuminates why
Since September of this year, stem cell biotechnology company Asymmetrex has been leading a campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine and the stem cell supply industry. During the month of November, the company is intensifying this effort with new educational publications and presentations at clinical
Is it possible to regrow cartilage? It is unclear whether the human body has the capacity to regrow cartilage after injury or even with normal joint wear during aging. In general, evidence for production of new cartilage after developmental maturation of joints is very limited. If regrowth does occur, it does not appear to be
Four months ago, alarms were set off by two reports showing that CRISPR-Cas9 gene editing of non-transformed human cells occurred with a high frequency of carcinogenic mutations in the p53 cancer gene. Though some experts worried that there would be no easy solution to this problem, published in today’s October issue of The CRISPR Journal,
True or False for Stem Cell Awareness Day 2018 is an excellent and needed RegMedNet feature. There are many misconceptions about stem cells in the research space, and even more misinformation or lacking information in the stem cell industrial space. These sometimes surprising deficits in knowledge and understanding inhibit progress in stem cell medicine and stem cell commercial
What are human pluripotent stem cells? Pluripotent stem cells are cells that have the ability to make in culture fetal-like cells that derive from any of the three main developmentally distinct layers of developing embryos. These layers are called endodermal, mesodermal, and ectodermal. Each layer gives rise to mature cells in the organs and tissues
What is cryopreservation? Preserving by freezing, usually at extremely low temperatures (e.g., ≤ 130^oC). What is cryopreservation of cells? Freezing cells in a manner in which they remain viable after thawing. What is a blood spinning machine used for? To separate the cellular components of unclotted blood (red blood cells and white blood cells) from